Literature DB >> 28297712

CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses.

Benjamin Descours1, Gaël Petitjean1, José-Luis López-Zaragoza2,3,4, Timothée Bruel2,5, Raoul Raffel1, Christina Psomas6, Jacques Reynes6, Christine Lacabaratz2,3,4, Yves Levy2,3,4, Olivier Schwartz2,5, Jean Daniel Lelievre2,3,4, Monsef Benkirane1.   

Abstract

The persistence of the HIV reservoir in infected individuals is a major obstacle to the development of a cure for HIV. Here, using an in vitro model of HIV-infected quiescent CD4 T cells, we reveal a gene expression signature of 103 upregulated genes that are specific for latently infected cells, including genes for 16 transmembrane proteins. In vitro screening for surface expression in HIV-infected quiescent CD4 T cells shows that the low-affinity receptor for the immunoglobulin G Fc fragment, CD32a, is the most highly induced, with no detectable expression in bystander cells. Notably, productive HIV-1 infection of T-cell-receptor-stimulated CD4 T cells is not associated with CD32a expression, suggesting that a quiescence-dependent mechanism is required for its induction. Using blood samples from HIV-1-positive participants receiving suppressive antiretroviral therapy, we identify a subpopulation of 0.012% of CD4 T cells that express CD32a and host up to three copies of HIV DNA per cell. This CD32a+ reservoir was highly enriched in inducible replication-competent proviruses and can be predominant in some participants. Our discovery that CD32a+ lymphocytes represent the elusive HIV-1 reservoir may lead to insights that will facilitate the specific targeting and elimination of this reservoir.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28297712     DOI: 10.1038/nature21710

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  100 in total

1.  Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells.

Authors:  Francesco Marras; Anna Casabianca; Federica Bozzano; Maria Libera Ascierto; Chiara Orlandi; Antonio Di Biagio; Emanuele Pontali; Chiara Dentone; Giancarlo Orofino; Laura Nicolini; Lucia Taramasso; Mauro Magnani; Francesco M Marincola; Ena Wang; Lorenzo Moretta; Andrea De Maria
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

2.  HIV: Marking the HIV hideout.

Authors:  Elisabeth Kugelberg
Journal:  Nat Rev Immunol       Date:  2017-03-27       Impact factor: 53.106

3.  Marking HIV.

Authors:  Ioana Visan
Journal:  Nat Immunol       Date:  2017-04-18       Impact factor: 25.606

4.  Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses.

Authors:  Benjamin Descours; Gaël Petitjean; José-Luis López-Zaragoza; Timothée Bruel; Raoul Raffel; Christina Psomas; Jacques Reynes; Christine Lacabaratz; Yves Levy; Olivier Schwartz; Jean Daniel Lelievre; Monsef Benkirane
Journal:  Nature       Date:  2017-06-28       Impact factor: 49.962

Review 5.  Barriers for HIV Cure: The Latent Reservoir.

Authors:  Sergio Castro-Gonzalez; Marta Colomer-Lluch; Ruth Serra-Moreno
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-28       Impact factor: 2.205

Review 6.  Review: HIV-1 phylogeny during suppressive antiretroviral therapy.

Authors:  Michael J Bale; Mary F Kearney
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

7.  Evidence that CD32a does not mark the HIV-1 latent reservoir.

Authors:  Christa E Osuna; So-Yon Lim; Jessica L Kublin; Richard Apps; Elsa Chen; Talia M Mota; Szu-Han Huang; Yanqin Ren; Nathaniel D Bachtel; Athe M Tsibris; Margaret E Ackerman; R Brad Jones; Douglas F Nixon; James B Whitney
Journal:  Nature       Date:  2018-09-19       Impact factor: 49.962

8.  Depletion of Gut-Resident CCR5+ Cells for HIV Cure Strategies.

Authors:  David Merriam; Connie Chen; Gema Méndez-Lagares; Kenneth A Rogers; Anthony J Michaels; Jiangli Yan; Paul Casaz; Keith A Reimann; François Villinger; Dennis J Hartigan-O'Connor
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11       Impact factor: 2.205

Review 9.  Getting the "Kill" into "Shock and Kill": Strategies to Eliminate Latent HIV.

Authors:  Youry Kim; Jenny L Anderson; Sharon R Lewin
Journal:  Cell Host Microbe       Date:  2018-01-10       Impact factor: 21.023

10.  Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death.

Authors:  Laurelle Jackson; Jessica Hunter; Sandile Cele; Isabella Markham Ferreira; Andrew C Young; Farina Karim; Rajhmun Madansein; Kaylesh J Dullabh; Chih-Yuan Chen; Noel J Buckels; Yashica Ganga; Khadija Khan; Mikael Boulle; Gila Lustig; Richard A Neher; Alex Sigal
Journal:  Elife       Date:  2018-03-20       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.